GU Cancers 2022 | Racial disparities in the field of bladder cancer treatment

Yeah, I think the key points I tried to get across in this is that a lot of the issues when it comes to gender and race disparities in bladder cancer are similar to disparities we see in other cancer types, but our characterization is what needs improvement. I think people jump to intervention without us clearly understanding what needs to change. And that’s entirely controlled by how we examine the data.

Well, I think big picture in terms of guideline-concordant care for bladder cancer, we know it’s underutilized already across the country and that proportion can change really, depending on where you’re getting your care within the country. Whether it’s at a center of excellence or a community center that does not have a lot of experience with bladder cancer. And I think that is one area that would kind of raise the tide for everyone to improve things across the board. I think at that point you can also start to narrow in on, okay, are there places where you’re seeing differences by specific groups? So within different racial groups, ethnic groups, within different socioeconomic classes treated in the same healthcare system, you can really start to drill things down, so you start to identify locations where you need intervention.